Table 1.
Characteristics of the Patients in the Overall Survival Group and Overall Death Group.
| Variable (unit: reference value) | Overall (n = 148) |
Overall survival group (n = 83) |
Overall death group (n = 65) |
p-value |
|---|---|---|---|---|
| Male/Female | 85/63 | 47/36 | 38/27 | 0.88 |
| Age (years) | 68.5 ± 11.4 | 64.4 ± 11.2 | 73.8 ± 9.6 | <0.01 |
| Body Mass Index (kg/m2) | 24.7 ± 4.2 | 22.6 ± 3.2 | 24.0 ± 2.9 | 0.39 |
| Duration on HD (months) | 94.3 ± 96.3 | 84.6 ± 85.0 | 106.6 ± 109.8 | 0.17 |
| Patients with Diabetes | 54 (36.5%) | 30 (36.1%) | 24 (36.9%) | 1 |
| Patients with a history of CVD | 78 (52.7%) | 33 (39.8%) | 45 (69.2%) | <0.01 |
| Patients taking phosphate binders | 96 (64.9%) | 62 (74.7%) | 34 (52.3%) | <0.01 |
| Patients taking antihyperlipidemic drugs | 8 (5.4%) | 7 (8.4%) | 1 (1.5%) | 0.08 |
| Patients taking antihypertensive drugs | 63 (42.6%) | 36 (43.4%) | 27 (41.5%) | 0.78 |
| FIF (days/week) | <0.01 | |||
| 0-1 day | 32 (21.6%) | 26 (31.3%) | 6 (9.2%) | |
| 2-3 days | 68 (45.9%) | 43 (51.8%) | 25 (38.5%) | |
| 4-5 days | 29 (19.6%) | 9 (10.8%) | 20 (30.8%) | |
| everyday | 19 (12.8%) | 5 (6.0%) | 14 (21.5%) | |
| Blood sampling data | ||||
| WBC (/μL: 3100-8400) | 5056 ± 1642 | 5186 ± 1687 | 4821 ± 1672 | 0.34 |
| Hemoglobin (g/dL: 11.4-16.6) | 10.2 ± 1.62 | 10.38 ± 1.68 | 10.19 ± 1.26 | 0.64 |
| CRP (mg/L: 0.0-0.3) | 0.33 ± 0.58 | 0.22 ± 0.45 | 0.48 ± 0.74 | <0.01 |
| Albumin (g/L: 3.8-5.3) | 3.5 ± 0.40 | 3.35 ± 0.69 | 3.50 ± 0.41 | 0.13 |
| P (mg/L: 2.5-4.5) | 5.7 ± 1.5 | 5.86 ± 1.57 | 5.42 ± 1.37 | 0.08 |
| K (mEq/L: 3.5-5.0) | 4.9 ± 0.8 | 4.99 ± 0.85 | 4.75 ± 0.74 | 0.07 |
| TG (mg/dl: 20-149) | 97.9 ± 60.8 | 106.9 ± 69.4 | 85.8 ± 447 | 0.03 |
| T-Chol (mg/dl: 140-199) | 143.1 ± 32.8 | 150.3 ± 33.8 | 134.5 ± 29.0 | <0.01 |
| HDL-c (mg/dl: ≥40) | 41.8 ± 12.8 | 43.9 ± 13.6 | 39.8 ± 11.4 | 0.06 |
| LDL-c (mg/dl: 60-119) | 81.0 ± 25.6 | 85.1 ± 26.1 | 76.3 ± 24.1 | 0.04 |
| DHA (μg/mL: 54.8-240.3) | 92.5 ± 33.4 | 91.2 ± 36.2 | 93.7 ± 29.7 | 0.66 |
| EPA (μg/mL: 10.2-142.3) | 52.9 ± 32.4 | 52.4 ± 32.5 | 52.6 ± 32.4 | 0.97 |
| ARA (μg/mL: 135.7-335.3) | 144.4 ± 40.6 | 147.6 ± 41.6 | 139.0 ± 39.1 | 0.20 |